Clinical Trials Browser

Phase 1/2 × Colonic Neoplasms × folfirinox × Clear all

NCT05121038 2024-12-17

CENDIFOX

Phase 1/2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms